Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

3407889 Title: COMPOSÉS ORGANIQUES ET LEUR UTILISATION DANS LE TRAITEMENT OU LA PRÉVENTION DE MALADIES DU SYSTÈME NERVEUX CENTRAL

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
177712858
WO application number:
US2017024137
Type:
European patent granted for BE
Status:
Open
Publication number:
3407889
WO publication number:
WO2017165843
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
24/03/2017
Grant date:
19/05/2021
EP publication date:
05/12/2018
WO publication date:
28/09/2017
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
19/05/2021
EP B1 publication date:
19/05/2021
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
24/03/2037

Applicant

Name:
Intra-Cellular Therapies, Inc.
Legal Form:
From:
19/05/2021
Address:
430 East 29th Street, Suite 900, New York, NY 10016, United States (US)
To:

Agent

Name:
DENNEMEYER & ASSOCIATES
Legal Form:
From:
22/06/2021
Address:
Rue des Bruyères 55, 1274, Howald, Luxembourg (LU)
To:

Inventor

1

Name:
YAO, Wei
Legal Form:
Address:
New York, New York 10016, United States (US)

2

Name:
LI, Peng
Legal Form:
Address:
New York, New York 10016, United States (US)

Priority

Priority patent number:
201662313629 P
Priority date:
25/03/2016
Priority country:
United States (US)

Classification

IPC or IDT classification:
A61K 31/4985; A61K 31/519; A61K 31/5383; A61K 45/06; A61P 25/00; A61P 25/18; A61P 25/24; A61P 25/28; C07D 471/14;

Publication

Bulletin

Bulletin heading:
EP2
Journal edition number:
2021/10
Publication date:
28/06/2021
Description:
Contains data concerning European patents granted and published (B1 publication) for Belgium and for which no translation needed to be filed

European Patent Bulletin

1

Issue number:
202120
Publication date:
19/05/2021
Description:
Grant (B1)

2

Issue number:
202123
Publication date:
09/06/2021
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual fee

Annual fee(s) Due Date:
31/03/2026
Annual fee number:
10
Annual fee amount:
185 Euro
Expected payer:
Last annual fee payment date:
18/03/2025
Last annual fee paid number:
9
Last annual fee paid amount:
165 Euro
Payer:
C.P.A.
Filing date Document type Publication Type Document Description Number of pages File Type
28/06/2021 Incoming Correspondence (Email) Cover letter 1 PDF /7/3/3/4/2/0722124337/docs/177712858_0_incomingcorrespondenceelectronic_20210629_084555417.pdf
28/06/2021 General Document Declaration of domicile 1 PDF /7/3/3/4/2/0722124337/docs/177712858_1_generaldocument_20210629_084554953.pdf